Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lowering blood pressure. How far, how fast?

A Roca-Cusachs1

  • 1Unidad de Hipertensión, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Drugs
|January 1, 1993
PubMed
Summary

Gradually lowering high blood pressure (BP) is crucial. Overly aggressive BP reduction risks organ damage, while moderate reduction protects against stroke and some heart disease, though coronary protection has limitations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2010
Same author

Urinary albumin excretion is associated with true resistant hypertension.

Journal of human hypertension·2009
Same author

[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg].

Revista clinica espanola·2005
Same author

Blood pressure variability and leukoaraiosis amount in cerebral small-vessel disease.

Acta neurologica Scandinavica·2002
Same author

[Quality of life questionnaire for hypertension].

Atencion primaria·2002
Same author

Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.

Journal of cardiovascular pharmacology·2001

Area of Science:

  • Cardiology
  • Nephrology
  • Neurology

Background:

  • High blood pressure (BP) management requires careful consideration of gradual reduction to avoid organ ischemia.
  • While BP reduction offers protection against cerebrovascular events, its impact on coronary heart disease is complex.
  • The 'J-shaped curve' phenomenon and morning BP surges may limit the effectiveness of antihypertensive therapies for coronary protection.

Purpose of the Study:

  • To explore the nuances of gradual blood pressure reduction in managing hypertension.
  • To investigate the protective effects and limitations of blood pressure lowering on cardiovascular and cerebrovascular events.
  • To examine factors influencing the efficacy of antihypertensive drugs, particularly concerning morning cardiovascular events.

Main Methods:

  • Review of existing literature on blood pressure autoregulation and organ perfusion.
  • Analysis of studies examining the relationship between blood pressure reduction and cardiovascular/cerebrovascular outcomes.
  • Investigation into the temporal patterns of cardiovascular events and antihypertensive drug efficacy.

Main Results:

  • Excessive BP reduction can compromise vital organ perfusion, leading to ischemia.
  • BP reduction provides significant protection against cerebral events and some protection against coronary heart disease.
  • The 'J-shaped curve' and morning peak in cardiovascular events may explain limited coronary protection with certain antihypertensive treatments.

Conclusions:

  • Gradual blood pressure reduction is essential to balance therapeutic benefits with the risk of organ ischemia.
  • Optimizing antihypertensive strategies requires understanding the 'J-shaped curve' and chronopharmacology to enhance coronary protection.
  • Further research is needed to fully elucidate the mechanisms behind limited coronary protection and to develop more effective antihypertensive regimens.

Related Experiment Videos